Cargando…
PHIL and Squid Embolization of Cerebral Arteriovenous Malformation: A Retrospective Case Series of 23 Patients
Precipitating hydrophobic injectable liquid (PHIL; MicroVention, Aliso Viejo, CA, USA) and Squid (Balt, Irvine, CA, USA) are 2 newer liquid embolic agents used in endovascular embolization of cerebral arteriovenous malformation (AVM). This study aims to investigate and compare the effectiveness and...
Autores principales: | Cheung, Eric Yuk Hong, Ng, Rebecca Yuen Ting, Yu, Simon Chun Ho, Zhuang, James Tin Fong, Wong, George Kwok Chu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Interventional Neuroradiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626609/ https://www.ncbi.nlm.nih.gov/pubmed/36039561 http://dx.doi.org/10.5469/neuroint.2022.00199 |
Ejemplares similares
-
Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas
por: Vollherbst, Dominik F., et al.
Publicado: (2021) -
Peripheral Arteriovenous Malformation Embolization Using Squid
por: Ahmad, Saima, et al.
Publicado: (2023) -
Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report
por: Kurda, Dylan, et al.
Publicado: (2019) -
Endovascular embolization for cases of ‘hidden’ pediatric cerebral arteriovenous malformations: A diagnostic & therapeutic challenge
por: Parenrengi, Muhammad Arifin, et al.
Publicado: (2021) -
Endovascular embolization of canine hepatic arteriovenous malformations using precipitating hydrophobic injectable liquid (PHIL) liquid embolic agent: a proof of concept study
por: Ryan, Stewart D., et al.
Publicado: (2019)